Arix Bioscience plc — Form D/A
Arix Bioscience plc of LONDON, X0, a company, filed a Form D amendment with the SEC on 2017-03-13. The offering totals $124.6M, of which $17.9M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2017-03-13
- Form: D/A
- Accession: 0001700449-17-000003
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $124.6M
- Amount sold: $17.9M
- Remaining: $106.6M
- Investors: 4
- Date of first sale: 2017-02-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-282151
Issuer
- Name: Arix Bioscience plc
- CIK: 0001700449
- Entity type: Other
- Jurisdiction: UNITED KINGDOM
- Incorporated: 2015
- Address: 20 BERKELEY SQUARE, LONDON, X0, W1J 6EQ
- Phone: 44(0)20 7290 1050
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| John Banham | Director | LONDON, X0 |
| John Mutton of Furness | Director | LONDON, X0 |
| Franz Humer | Director | LOS ANGELES, CA |
| Joseph Anderson | Director | South Burlington, VT |
| Joseph Anderson | Executive Officer | South Burlington, VT |
| Trevor Jones | Director | Manhattan, KS |
| JONATHAN PEACOCK | Director | LONDON, X0 |
| JONATHAN PEACOCK | Executive Officer | LONDON, X0 |
| JOHN HUTTON OF FURNESS | Director | LONDON, X0 |
| MEGHAN MAIR FITZGERALD | Director | LONDON, X0 |
| GILES MAIR KERR | Director | LONDON, X0 |
| DAVID U'PRICHARD | Director | LONDON, X0 |
| JAMES RAWLINGSON | Director | LONDON, X0 |
| JAMES RAWLINGSON | Executive Officer | LONDON, X0 |
| CHRISTOPHER EVANS | Director | Zebulon, NC |
| CHRISTOPHER EVANS | Executive Officer | Zebulon, NC |
Other filings by this issuer (2)
More